PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.01%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.20%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-9.43%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-9.43%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-12.60%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-10.98%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-11.13%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.83%
Share reduction while MTDR is at 0.03%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.69%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-5.60%
Dividend reduction while MTDR stands at 99.84%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-28.42%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-45.86%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
101.88%
10Y revenue/share CAGR under 50% of MTDR's 935.14%. Michael Burry would suspect a lasting competitive disadvantage.
217.71%
5Y revenue/share CAGR under 50% of MTDR's 465.75%. Michael Burry would suspect a significant competitive gap or product weakness.
98.77%
3Y revenue/share CAGR at 50-75% of MTDR's 197.17%. Martin Whitman would question if the firm lags behind competitor innovations.
-50.89%
Negative 10Y OCF/share CAGR while MTDR stands at 804.82%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
107.70%
Below 50% of MTDR's 367.22%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
33.35%
3Y OCF/share CAGR under 50% of MTDR's 246.67%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
155.59%
Below 50% of MTDR's 1817.26%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
210.93%
Below 50% of MTDR's 1806.99%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
734.12%
3Y net income/share CAGR 1.25-1.5x MTDR's 658.32%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
-30.80%
Negative equity/share CAGR over 10 years while MTDR stands at 235.03%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-27.52%
Negative 5Y equity/share growth while MTDR is at 168.02%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-30.81%
Negative 3Y equity/share growth while MTDR is at 57.23%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-76.47%
Cut dividends over 10 years while MTDR stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
226.56%
Dividend/share CAGR of 226.56% while MTDR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
158.99%
3Y dividend/share CAGR of 158.99% while MTDR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-16.39%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
100.00%
Inventory growth well above MTDR's 9.17%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-3.68%
Negative asset growth while MTDR invests at 6.88%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
14.62%
1.25-1.5x MTDR's 11.77%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-7.25%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
9.78%
SG&A growth well above MTDR's 12.76%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.